Pegapamodutide, a cutting-edge biomedical marvel, emerges as a beacon of hope in the quest to mitigate the multifaceted manifestations of type 2 diabetes. Through intricate interactions with the esteemed GLP-1 receptors, this transcendent pharmaceutical masterpiece exerts its influence, stimulating insulin secretion contingent upon glucose levels and meticulously overseeing the delicate balance of blood glucose.
CAT No: R2066
CAS No:1492924-65-8
Synonyms/Alias:Pegapamodutide;Pegapamodutide [USAN];UNII-WG4ID2U7FT;WG4ID2U7FT;LY2944876;Pegapamodutide (USAN);pegapamodutida;pegapamodutidum;CAS Registry Number;PEGAPAMODUTIDE [INN];PEGAPAMODUTIDE [WHO-DD];LY-2944876;Q27292621;1492924-65-8;
Chemical Name:(2R)-2-amino-3-[1-[3-[3-(2-methoxyethoxy)propylamino]-3-oxopropyl]-2,5-dioxopyrrolidin-3-yl]sulfanylpropanoic acid
4. Emu oil in combination with other active ingredients for treating skin imperfections
5. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.